MARSHALL WACE, LLP - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 33 filers reported holding INMUNE BIO INC in Q1 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of INMUNE BIO INC
ValueSharesWeighting
Q1 2022$568,000
-2.9%
67,373
+17.4%
0.00%0.0%
Q4 2021$585,000
-53.4%
57,382
-11.2%
0.00%
-80.0%
Q3 2021$1,256,00064,6500.01%
Other shareholders
INMUNE BIO INC shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders